Lemsip Multirelief capsules *

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15 January 2020

File name

Lemsip Multi Relief Capsules_1579099305.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 28 February 2018

Reasons for updating

  • Change to section 9 - Date of first authorisation/renewal of the authorisation

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Approval of Renewal date added to Section 9 (Renewal approval received Jan 2018)

Updated on 28 February 2018

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Updated on 02 March 2017

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store or dispose

Updated on 02 March 2017

File name

PIL_14939_142.pdf

Reasons for updating

  • New PIL for new product

Updated on 01 December 2016

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.5:
Additional information for paracetamol & phenylephrine HCl interactions

Section 4.6:
Additional safety data on phenylephrine HCl

Section 4.7:
Addition of "No or negligible influence on ability to drive or use machinery"

Section 4.8:
Addition of blood dyscrasias symptoms
Addition of hypersensitivity reactions as an adverse reaction for Guaifenesin.

Section 4.9:
Addition o f overdose data for paracetamol and phenylephrine HCl


Updated on 03 December 2012

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 6.3, the shelf-life has changed from 2-3 years
In section 10, the date of revision of the text has changed to November 2012

Updated on 30 March 2011

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

None provided

Updated on 29 March 2011

Reasons for updating

  • New PIL for new product